LRP6 and prostate cancer: In the present study, we found niclosamide inhibited the proliferation of prostate cancer PC-3 and DU145 cells with IC50 values less than 1 μM, which are comparable to those shown to suppress LRP6 expression and the activities of Wnt/β-catenin signaling in prostate cancer cells.